Codon Usage Bias Correlates With Gene Length in Neurodegeneration Associated Genes.

codon preference codon usage bias compositional bias gene length neurodegeneration

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2022
Historique:
received: 14 03 2022
accepted: 08 06 2022
entrez: 21 7 2022
pubmed: 22 7 2022
medline: 22 7 2022
Statut: epublish

Résumé

Codon usage analysis is a crucial part of molecular characterization and is used to determine the factors affecting the evolution of a gene. The length of a gene is an important parameter that affects the characteristics of the gene, such as codon usage, compositional parameters, and sometimes, its functions. In the present study, we investigated the association of various parameters related to codon usage with the length of genes. Gene expression is affected by nucleotide disproportion. In sixty genes related to neurodegenerative disorders, the G nucleotide was the most abundant and the T nucleotide was the least. The nucleotide T exhibited a significant association with the length of the gene at both the overall compositional level and the first and second codon positions. Codon usage bias (CUB) of these genes was affected by pyrimidine and keto skews. Gene length was found to be significantly correlated with codon bias in neurodegeneration associated genes. In gene segments with lengths below 1,200 bp and above 2,400 bp, CUB was positively associated with length. Relative synonymous CUB, which is another measure of CUB, showed that codons TTA, GTT, GTC, TCA, GGT, and GGA exhibited a positive association with length, whereas codons GTA, AGC, CGT, CGA, and GGG showed a negative association. GC-ending codons were preferred over AT-ending codons. Overall analysis indicated that the association between CUB and length varies depending on the segment size; however, CUB of 1,200-2,000 bp gene segments appeared not affected by gene length. In synopsis, analysis suggests that length of the genes correlates with various imperative molecular signatures including A/T nucleotide disproportion and codon choices. In the present study we additionally evaluated various molecular features and their correlation with different indices of codon usage, like the Codon Adaptation Index (CAI) and Relative Dynonymous Codon Usage (RSCU) of codons. We also considered the impact of gene fragment size on different molecular features in genes related to neurodegeneration. This analysis will aid our understanding of and in potentially modulating gene expression in cases of defective gene functioning in clinical settings.

Identifiants

pubmed: 35860292
doi: 10.3389/fnins.2022.895607
pmc: PMC9289476
doi:

Types de publication

Journal Article

Langues

eng

Pagination

895607

Informations de copyright

Copyright © 2022 Khandia, Saeed, Alharbi, Ashraf, Greig and Kamal.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Rev Mol Cell Biol. 2004 Oct;5(10):827-35
pubmed: 15459663
Nucleic Acids Res. 1987 Feb 11;15(3):1281-95
pubmed: 3547335
Mol Biol Evol. 2007 Feb;24(2):611-9
pubmed: 17150976
J Mol Evol. 2000 Mar;50(3):249-57
pubmed: 10754068
Front Genet. 2021 Feb 11;12:559998
pubmed: 33643374
J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):329-35
pubmed: 22323772
J Clin Med. 2020 Apr 08;9(4):
pubmed: 32276438
BMC Evol Biol. 2004 Jun 28;4:19
pubmed: 15222899
Nucleic Acids Res. 1987 Oct 12;15(19):8023-40
pubmed: 3118331
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10231-6
pubmed: 21646514
Sci Rep. 2022 Mar 17;12(1):4631
pubmed: 35301412
Dis Model Mech. 2017 May 1;10(5):499-502
pubmed: 28468935
Nucleic Acids Res. 1990 Apr 11;18(7):1859-67
pubmed: 2336360
Protein Pept Lett. 2010 May;17(5):630-45
pubmed: 20441557
Bioinformatics. 2015 Oct 1;31(19):3081-4
pubmed: 26019240
Phys Biol. 2020 Apr 08;17(3):031002
pubmed: 31986496
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4482-7
pubmed: 10200288
J Microbiol Biotechnol. 2016 Nov 28;26(11):1972-1982
pubmed: 27470283
Front Genet. 2021 Aug 20;12:732432
pubmed: 34490050
EMBO Rep. 2019 Nov 5;20(11):e48220
pubmed: 31482640
PLoS One. 2018 Mar 27;13(3):e0194372
pubmed: 29584741
Mol Phylogenet Evol. 2016 Jan;94(Pt A):34-46
pubmed: 26291569
Genetics. 2005 Aug;170(4):1691-700
pubmed: 15937136
J Exp Zool B Mol Dev Evol. 2019 May;332(3-4):99-112
pubmed: 31033182
Mol Biol Evol. 1996 Jul;13(6):864-72
pubmed: 8754221
Comput Struct Biotechnol J. 2021 Apr 22;19:2646-2663
pubmed: 34025951
BMC Genomics. 2016 Mar 12;17:225
pubmed: 26968808
Biomed Pharmacother. 2022 Apr;148:112730
pubmed: 35183996
Front Microbiol. 2017 Jul 27;8:1419
pubmed: 28798739
Cell Cycle. 2017 Feb;16(3):259-270
pubmed: 28055303
J Clin Invest. 2003 Jan;111(1):3-10
pubmed: 12511579
Arch Neurol. 2009 Feb;66(2):201-7
pubmed: 19204156
Cold Spring Harb Symp Quant Biol. 2003;68:245-54
pubmed: 15338624
PLoS One. 2012;7(8):e43111
pubmed: 22912801
J Mol Evol. 2001 Mar;52(3):275-80
pubmed: 11428464
Trends Ecol Evol. 2004 Jun;19(6):309-14
pubmed: 16701276
Genome Biol Evol. 2019 Dec 1;11(12):3523-3528
pubmed: 31800035
Genome Biol. 2007;8(3):R35
pubmed: 17349061
Nature. 2018 Mar 1;555(7694):117-120
pubmed: 29466333
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
PLoS Genet. 2011 Sep;7(9):e1002283
pubmed: 21935355
Biol Direct. 2008 Sep 16;3:38
pubmed: 18796141
Materials (Basel). 2022 Jan 21;15(3):
pubmed: 35160749
Front Genet. 2019 Sep 05;10:771
pubmed: 31543897
J Helminthol. 2017 Jan;91(1):72-79
pubmed: 27048929
Front Neurosci. 2020 Sep 18;14:580179
pubmed: 33071748
BMC Genomics. 2017 Apr 20;18(1):308
pubmed: 28427327
Genome Res. 2014 Sep;24(9):1497-503
pubmed: 25015383
BMC Evol Biol. 2007 Feb 08;7 Suppl 1:S6
pubmed: 17288579
J Mol Evol. 1986;24(1-2):28-38
pubmed: 3104616
J Integr Neurosci. 2021 Dec 30;20(4):905-918
pubmed: 34997714
Nucleic Acids Res. 1998 Jul 1;26(13):3188-93
pubmed: 9628917
Gene X. 2019 Mar 06;2:100012
pubmed: 32550546
Genome Res. 2003 Oct;13(10):2260-4
pubmed: 12975314
Virol J. 2011 Mar 30;8:146
pubmed: 21450075

Auteurs

Rekha Khandia (R)

Department of Biochemistry and Genetics, Barkatullah University, Bhopal, India.

Mohd Saeed (M)

Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia.

Ahmed M Alharbi (AM)

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia.

Ghulam Md Ashraf (GM)

Pre-clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.

Nigel H Greig (NH)

Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program National Institute on Aging, NIH, Baltimore, MD, United States.

Mohammad Amjad Kamal (MA)

Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Enzymoics, Novel Global Community Educational Foundation, Hebersham, NSW, Australia.

Classifications MeSH